# What Published Guidance Describes About Bone Grafting Before Dental Implants

> What implant survival ranges do published systematic reviews report for grafted and non-grafted sites, what does a hospital trust's own patient document say a bone graft is for, and what does the published work say about how long healing takes? This page quotes those sources with their follow-up periods and their scope limits attached, and separates survival from an absence of complications.

- Language: English
- Page: https://smilehandbook.com/en/bone-grafting-for-dental-implants/
- All published pages: https://smilehandbook.com/llms-full.txt

## What do published sources say a bone graft is for?

Cambridge University Hospitals NHS Foundation Trust, in document ID 101926, version 3, approved 15 July 2024, publishes patient information called Bone grafting for dental implants, and it answers the purpose question in two sentences: "Bone grafting is any technique used to increase the amount of bone that you have in your jaw to help the best positioning of your dental implant. In order to have an implant, you must have sufficient bone at the implant site." What the trust states there is a condition rather than an outcome: why the procedure is carried out, and what has to be true before an implant can be placed. Hospital patient information is not peer-reviewed evidence, so that definition is quoted as the trust's own wording, and the outcome figures in this section are carried by two named systematic reviews, PMID 39555856 and PMID 27765427.

Two registers of published source answer this question, and they are not interchangeable. Our methodology page sets out an order of preference — the regulation or law in its own words, then whatever the institution holding the authority publishes itself, then peer-reviewed clinical literature, then guidance issued by professional bodies — and it labels a statement drawn from a named authority's own publication differently from one drawn from peer-reviewed research. A hospital trust's leaflet falls under the first of those two labels, and it is quoted here for what a graft is and what it is meant to do. The survival figures on this page each carry the PMID of the systematic review that reported them, because a leaflet describing a procedure is not a study that measured its outcome.

The peer-reviewed literature reaches the purpose question sideways, by comparing implants placed in grafted sites with implants placed in sites that were never grafted. A systematic review published in Oral Health & Preventive Dentistry in 2024 under the title Dental Implants Placed in Grafted and Non-Grafted Sites: A Systematic Review (PMID 39555856, DOI 10.3290/j.ohpd.b5828032) reports its band in one sentence: "The reported ISR ranged between 91.6% and 100%." ISR is the implant survival rate. A band that wide is a range across the studies a review included, not a figure for one patient or one clinic, and nothing in the sentence identifies a country, a practitioner or a technique.

Whether the graft material itself changes the outcome has been tested directly in sinus surgery. The systematic review Maxillary sinus lift surgery-with or without graft material?, published in the International Journal of Oral and Maxillofacial Surgery in 2016 (PMID 27765427, DOI 10.1016/j.ijom.2016.09.023), reports: "The implant survival rate was 96.00% for surgeries performed without graft material and 99.60% for those in which biomaterial was used, within a follow-up period of 48 to 60 months." Both arms of that comparison are sinus lift operations. The review is not comparing grafting with leaving the mouth alone; it is comparing lifting the sinus floor with material against lifting it without.

Survival is a narrower unit than the word success suggests. An implant survival rate counts implants still present at the end of a stated follow-up period, which is not the same measurement as an absence of problems: an implant can be counted as surviving and still have caused trouble along the way. The 2024 systematic review in Oral Health & Preventive Dentistry (PMID 39555856) and the 2016 sinus lift review in the International Journal of Oral and Maxillofacial Surgery (PMID 27765427) both report their figures as survival, and this page reports them in that unit. Reading a survival percentage as an absence of trouble would overstate what was measured, and our corrections page counts overstating the strength of a claim as a correction.

Two sources a reader might expect on this subject were searched for and are not there, and the absence was measured rather than assumed. The National Institute for Health and Care Excellence site returns no results for the quoted phrase dental implant, and its results for the unquoted phrase concern reflux surgery, orthodontic anchorage, osteoporosis risk and local authority oral health rather than tooth replacement. On the NHS website, the dedicated dental implants address returns an error page, and a search for bone graft returns results about bone cancer, bone cysts, Paget's disease, coronary bypass grafts and stem cell transplants. Under the rules our methodology page sets out, a gap found by searching is recorded as a gap rather than filled with general knowledge.

What the peer-reviewed line adds to a hospital definition is a comparison the hospital leaflets do not make. The systematic review of intraoral onlay block bone grafts published in Medicina Oral, Patología Oral y Cirugía Bucal in 2015 (PMID 25662543, DOI 10.4317/medoral.20194) by Aloy-Prósper A, Peñarrocha-Oltra D, Peñarrocha-Diago M and Peñarrocha-Diago M concludes: "Survival and success rates of implants placed in horizontally and vertically resorbed edentulous ridges reconstructed with block bone grafts are similar to those of implants placed in native bone, in distracted sites or with guided bone regeneration." Read through that sentence, the purpose of a graft is to make a resorbed ridge behave like a site that never lost bone. The comparison drawn there is with other ways of rebuilding a ridge rather than with leaving it alone, and it covers block grafts and nothing else.

## When do published sources describe grafting relative to implant placement?

Cambridge University Hospitals NHS Foundation Trust answers the timing question with a threshold rather than a rule, in its patient information on bone grafting for dental implants: "If minimal bone grafting is required, it can be carried out at the time of your implant placement. If more extensive grafting is required, it will be carried out at least four months before your implant placement." The variable in those two sentences is how much bone has to be built. What the wording establishes is that both sequences exist in NHS practice: one operation, or two operations separated by months. The trust is quoted for that description; the outcome comparison between the two sequences is carried by peer-reviewed records, PMID 25662543 and PMID 33724473.

Two words carry the trust's timing threshold, and neither is defined in numbers. Cambridge University Hospitals NHS Foundation Trust, in document ID 101926, writes minimal and more extensive without attaching a measurement to either, so a reader cannot work out from the leaflet alone which of the two sequences applies to them. What the peer-reviewed records add is not a replacement figure but a comparison: PMID 25662543 asks whether the two sequences produce different implant outcomes, and PMID 33724473 measures the bone around implants placed each way. The four-month figure is the trust's, and the outcome comparisons are the reviews'.

The same pair of sequences is the research question of a peer-reviewed systematic review. Aloy-Prósper A, Peñarrocha-Oltra D, Peñarrocha-Diago M and Peñarrocha-Diago M, writing in Medicina Oral, Patología Oral y Cirugía Bucal in 2015 (PMID 25662543, DOI 10.4317/medoral.20194), set out to answer whether ridge augmentation "in conjunction with or prior to implant placement influence implant outcome when compared with a control group". The authors put the choice inside a single question, which is how this literature treats it: not as a fixed protocol handed to every patient, but as two options whose published outcomes can be set against each other.

What that review counted is narrower than the word grafting suggests, and its title says so: The outcome of intraoral onlay block bone grafts on alveolar ridge augmentations: a systematic review. Its result is reported as two bands rather than one: "For lateral augmentation procedures, implant survival rates ranged from 96.9% to 100%, while for vertical augmentation they ranged from 89.5% to 100%." Lateral and vertical augmentation are different operations with different published bands, and neither band covers sinus floor grafting, socket preservation, or any technique other than intraoral onlay block grafts (PMID 25662543).

A warning is attached to the harder of those two operations, in the concluding words of the same 2015 systematic review (PMID 25662543): "More surgical challenges and morbidity arise from vertical augmentations, thus short implants may be a feasible option." A separate systematic review approaches timing from the sinus floor and finds no effect at all. Nkenke E and Stelzle F, in Clinical Oral Implants Research in 2009 (PMID 19663959, DOI 10.1111/j.1600-0501.2009.01776.x), report that "Length of healing period, simultaneous implant placement or a staged approach or the height of the residual alveolar crest, sinusitis or graft loss did not modify the lack of effect of graft material on the outcomes."

A five-year randomised controlled trial tested the two sequences head to head in the front of the mouth. Slagter KW, Meijer HJA, Hentenaar DFM, Vissink A and Raghoebar GM, at the University Medical Center Groningen, published it in the Journal of Periodontology in 2021 (PMID 33724473, DOI 10.1002/JPER.20-0845) and report: "Mean marginal bone level change was -0.71 ± 0.35 mm and -0.54 ± 0.41 mm in respectively the Immediate group and the Delayed group after 5 years (P = 0.202)." Their conclusion is written as a comparison: outcomes after immediate placement with simultaneous bone augmentation "were comparable to those following delayed implant placement after ridge preservation in the esthetic zone."

How the rest of that trial's timetable ran is stated in its methods: "Second-stage surgery and placement of a provisional restoration occurred 3 months after implant placement in both groups, followed by definitive restorations 3 months thereafter." Two limits travel with the result. The trial randomised twenty patients to each arm, all five authors give the University Medical Center Groningen as their address, and every socket it treated carried a buccal bony defect in the esthetic region. A finding of no significant difference between two small groups is not a proof that the two approaches are equivalent, because it can equally mean the trial was too small to show a difference that exists (PMID 33724473).

Whether the two peer-reviewed sources behind this section are really two was measured rather than assumed. Their author lines share no name, the work comes from Valencia and from Groningen, one is a systematic review and the other a primary randomised trial, and the reference list of the Groningen record does not contain the Valencia one. One candidate failed that test and is therefore quoted only as support: a 2020 systematic review of the bone ring technique (PMID 33313968) carries the Valencia review inside its own reference list, and it describes "a one-stage approach to restore vertical alveolar ridge defects, in which an autogenous or allogeneic cortico-cancellous bone block graft is stabilized with a dental implant inserted simultaneously".

## What is published about healing time?

Cambridge University Hospitals NHS Foundation Trust, in document ID 101926, describes healing in terms of what the graft material does rather than how the patient feels, in its patient information on bone grafting for dental implants: "The graft material creates a scaffold for your own bone to grow into. This process may take between four and twelve months." A window running from four months to twelve is a wide one, and the trust prints it as a range rather than as an expected date. A separate timetable is given where bone is taken from the hip: "After four to six months the bone grafts will have healed and your dental implants can be placed." What forms inside a graft over that period was measured in PMID 27534916 and PMID 36714084.

Healing time is an explicit variable in the peer-reviewed literature. Danesh-Sani SA, Engebretson SP and Janal MN, of New York University College of Dentistry, published a systematic review and meta-analysis in the Journal of Periodontal Research in 2017 (PMID 27534916, DOI 10.1111/jre.12402) whose title names it: Histomorphometric results of different grafting materials and effect of healing time on bone maturation after sinus floor augmentation. The review sorted its evidence by that variable before analysing anything: "extracted data were classified into three groups based on healing time: (i) ≤ 4.5 mo; (ii) 4.5-9 mo; and (iii) ≥ 9-13.5 mo."

What that meta-analysis found is a threshold rather than a slope, and reporting only its first half would misrepresent it. The first half reads: "a significant difference was noticed in the amount of NB formation in grafts with a healing time of > 4.5 mo when compared to the grafts with less healing time." The second half reads: "when comparing biopsies taken at 4.5-9 mo of healing (average = 6.22 mo) to the ones taken at ≥ 9-13.5 mo (average = 10.36 mo), no significant difference was noticed in the amount of NB formation of various grafts except allografts that resulted in a significantly higher percentage of NB at 9.5 mo of healing." Waiting longer did not keep adding new bone (PMID 27534916).

Two limits belong beside those healing figures. The object of that review is sinus floor augmentation, so its groups describe graft material placed under the floor of the maxillary sinus and cannot be read as a timetable for every graft in every part of the jaw. And the quantity being measured is NB, the amount of new bone found in a biopsy and expressed as a histomorphometric percentage. That is a laboratory measurement of tissue, not a count of implants that survived or failed, and the two remain different units even when they appear in the same sentence (PMID 27534916).

A randomised trial compared two waiting intervals directly, in extraction sockets rather than in the sinus. Moghaddas O, Naddafpour N, Farhadi S, Nikookar P and Khandan S, in the Journal of Advanced Periodontology and Implant Dentistry in 2022 (PMID 36714084, DOI 10.34172/japid.2022.020), describe the design: "Extraction sockets were preserved using a cortical FDBA allograft in two regeneration interval groups: 3 months (group A) and 4 months (group B)." Their result is an absence of difference: "There were no significant differences in the amount of newly formed bone and residual graft material between the two groups." Forty patients is a small base, and this page does not read a null result from a small trial as establishing that three months suffices.

How large the difference between three and four months was is printed by the trial itself. Moghaddas O, Naddafpour N, Farhadi S, Nikookar P and Khandan S report: "In general, the average of new bone formation and remaining graft particles in groups A and B was: %33.89 and %12.59 vs. %39.83 and %14.07, respectively." Group A is the three-month interval and group B the four-month one. The same abstract states "Bone parameters in group A were better compared to group B.", which does not follow in an obvious way from those averages, since the higher new-bone figure sits with group B. The authors draw their own conclusion from that absence: "However, due to the lack of significant differences in the results, it is suggested that implant placement in grafted sockets with mineralized allografts be expedited." That recommendation is theirs; this page reports it rather than adopting it (PMID 36714084).

One further peer-reviewed record shows a published interval inside a protocol, quoted as support rather than as a second independent source. A split-mouth randomised trial reported in the International Journal of Oral Implantology in 2019 (PMID 31090751) by Baldini N, D'Elia C, Mirra R and Ferrari M states: "Implants were inserted according to a two-stage technique 6 months after sinus elevation procedures, submerged and then loaded after 6 months with definitive screw-retained metal-ceramic prostheses." Its reference list is not indexed in the database used here to check whether one paper cites another, so the independence test could not be completed, and an unfinished check is recorded as unfinished under our methodology page.

## What is published about graft material types?

Cambridge University Hospitals NHS Foundation Trust, in document ID 101926, sorts graft materials by where they come from, in one sentence of its patient information on bone grafting for dental implants: "Bone grafting materials may be taken from you or other human, animal or synthetic sources." Four origins are named there — the patient, another person, an animal and a laboratory — and the trust does not rank them against each other. The same document names four techniques rather than four materials: guided bone regeneration, block grafting, bone expansion and distraction osteogenesis. How the materials compare on outcomes is left to two named peer-reviewed reviews, PMID 36162883 and PMID 27765427.

Product names appear in document ID 101926 itself. On the graft material, Cambridge University Hospitals NHS Foundation Trust writes: "The most commonly used material is Bio-Oss. This artificial bone comes from bovine (cattle) bone, which has been sterilised and treated to make it safe for use as a bone substitute in humans." On the membrane placed over it: "The most commonly used membrane is Bio-Gide, which is dissolvable. This artificial membrane comes from porcine (pig) origin." A reader who needs the animal origin of what will be placed in their jaw, for religious or dietary reasons, will find it in the trust's own words. Those two sentences are product statements by a single hospital trust, and no claim about how well a graft works is rested on them here.

Where a patient's own bone is harvested from changes the published survival figures. A systematic review and meta-analysis in the Journal of Evidence-Based Dental Practice in 2022 (PMID 36162883, DOI 10.1016/j.jebdp.2022.101731), on the effect of autogenous bone graft site on dental implant survival and donor site complications, reports: "The meta-analysis of included studies revealed that the implant survival rate of dental implants placed in jaws augmented with iliac crest grafts was lower than those placed in jaws augmented with intra-oral bone grafts". Autogenous means the patient's own bone and the iliac crest is the hip, so the comparison runs between two harvest sites in one person rather than between two commercial products.

How that gap moves with follow-up is printed in one sentence of the same meta-analysis: "at 6-months [ICG = 95.8% IOG = 98.4%; P < .001], 12-months [ICG = 97.0%, IOG = 98.4%; P < .001], 24-months [ICG = 85.9%, IOG = 98.2%; P < .001], 60-months [ICG = 90.0%, IOG = 91.5%; P < .001], and at 120-months [ICG = 88.8%, IOG = 95.2%; P < .001] follow-up periods." ICG is the iliac crest graft and IOG the intra-oral graft. The series does not fall smoothly in either arm, which is a property of pooled follow-up data across studies rather than of one patient's ten years (PMID 36162883).

Whether any material is used at all has also been tested. A systematic review of maxillary sinus lift surgery published in the International Journal of Oral and Maxillofacial Surgery in 2016 (PMID 27765427, DOI 10.1016/j.ijom.2016.09.023) reports: "The implant survival rate was 96.00% for surgeries performed without graft material and 99.60% for those in which biomaterial was used, within a follow-up period of 48 to 60 months." Both arms there are sinus lift operations, so the question being asked is about the biomaterial and not about whether to operate, and the follow-up window is stated by the review inside the same sentence as the two figures.

Which material produced the most new bone in sinus floor augmentation was measured, and the measure was histomorphometric rather than clinical. The meta-analysis by Danesh-Sani SA, Engebretson SP and Janal MN in the Journal of Periodontal Research in 2017 (PMID 27534916, DOI 10.1111/jre.12402) reports: "Autogenous bone (AB) resulted in the highest amount of NB and lowest amount of RG compared to other grafting materials." NB is the percentage of new bone in a biopsy, so that ranking describes tissue from under the maxillary sinus floor and not implant success elsewhere in the jaw. The same review says why that does not settle the choice: "Bone substitute materials (allografts, alloplastic materials and xenografts) seem to be good alternatives to autogenous bone and can be considered as grafting materials to avoid disadvantages related to AB, including morbidity rate, limited availability and high volumetric change." A further finding closes off a common assumption: "Combining AB with alloplastic materials and xenografts brings no significant advantages regarding NB formation."

Which material to choose has been examined and not settled. Nkenke E and Stelzle F, in Clinical Oral Implants Research in 2009 (PMID 19663959, DOI 10.1111/j.1600-0501.2009.01776.x), asked whether autogenous bone is superior to bone substitutes for sinus floor augmentation and concluded: "The retrieved evidence provides a low level of support for selection of AB or a bone substitute." The same review records a cost that only the patient's own bone carries: three of its included studies documented donor site morbidity after harvesting, harvesting from the iliac crest sometimes required hospitalisation and surgery under general anaesthesia, and taking bone extended the operating time.

## What does NHS England's policy say about who handles post-treatment issues?

NHS England published a clinical policy on 4 November 2024, under the publication reference PRN00784, that sets out when NHS dental care is provided after privately funded treatment. Its executive summary states the scope: "This note sets guidelines for when it is appropriate to provide NHS dental care after patients have received self-funded dental treatments, including privately funded non-NHS care within and outside of the UK, in cases where patients have acute presentations or complications." Treatment paid for abroad therefore sits inside the policy without any country being named, and a bone graft or an implant paid for privately falls under it in the same way as any other self-funded dental work.

What the NHS England policy offers after a complication is stated in one sentence: "Patients who have previously paid for dental treatment privately in the UK or abroad but later require NHS treatment due to a complication or sudden oral health issue are entitled to access NHS dental care for assessment and evaluation to stabilise their condition." Stabilisation is the word the policy uses, and it is carrying weight. Assessment and stabilisation are what the entitlement covers, and the policy continues: "Any treatment beyond stabilisation will be assessed based on complexity and need and should be provided at the appropriate care setting, subject to existing NHS acceptance criteria".

Who the NHS England policy expects to handle the problem first is written before the NHS route appears: "It is expected that patients would initially seek support from their self-funded dental care provider, who should be responsible for any post-treatment clinical issues within a reasonable timeframe." The provider named there is whoever carried out the self-funded treatment, wherever they are based. The policy does not say what happens when that provider is in another country, does not set out how the reasonable timeframe is to be counted, and creates no obligation on a provider outside the United Kingdom, because an NHS England policy cannot bind one.

Implants are named where the NHS England policy deals with complex reconstruction. Further care is made subject to existing criteria "Where a patient requests further complex elective reconstructive treatment not routinely available as part of NHS-funded dental care (for example, advanced multi-unit fixed appliances and/or implants)", and the criteria then listed include trust-based policies and acceptance criteria, existing NHS acceptance criteria, treatment-specific guidelines, NICE guidelines and guidance on the standard of care for NHS funded dental implant treatment. A graft placed to make an implant possible travels the same route as the implant it was placed for.

What the NHS England policy rests on is stated in a short principles section rather than argued for: "Based on NHS Constitution: providing appropriate care where needed." and "The NHS will provide the treatment necessary to secure and maintain the patient’s oral health." The route a patient actually travels is drawn as a flow chart in the same publication, and its first step is triage: "If a patient has self-funded treatment and has presented at a general dental practice (GDP) or community dental service (CDS) with an oral health issue related to that treatment, the GDP or CDS dental officer will triage the patient." The first question in that chart is whether the patient fits NHS acceptance criteria, and the policy records that if they do not, the process ends there.

One line of the NHS England clinical policy limits replacement directly: "Please note that self-funded care that the NHS would not routinely fund would not usually be offered or replaced once stabilisation has been achieved." Another line protects eligibility itself: "Where a patient has received their care previously does not impact on their eligibility for NHS care in the future." Read together, those two sentences separate access from replacement. Being seen by the NHS after a complication is not the same thing as having privately funded work rebuilt at NHS expense, and the policy puts each half in a sentence of its own.

## What does the GDC tell patients to ask about who will carry out the procedure?

The General Dental Council, the statutory regulator of dental professionals in the United Kingdom, publishes patient information called Going abroad for dental treatment, and prints a list of questions under a one-line instruction: "You may want to ask:". The first item on that list is about the person rather than the procedure: "Who will be carrying out my treatment and what qualifications do they have?" A bone graft is surgery, so the question reaches the operator as much as the clinic. The regulator does not tell patients what answer to expect, and this page does not supply one either.

Regulation is the second thing the General Dental Council list asks about, in the item "Are you regulated by a professional body and are you registered with them?" The regulator explains why it asks, in the same patient information: "We can’t guarantee another organisation like us exists in other countries, or even that the standards will be the same as they are here." It also sets an expectation about who assesses a patient before any plan is written: "You should always be assessed by a qualified dentist before being given a treatment plan and cost estimate." That sentence is about qualification and sequence, and names no country.

Three items on the General Dental Council list concern what happens when treatment does not go as planned, which matters for a bone graft because a graft is a stage rather than a finished result. The items read: "If there are complications and I need further treatment, is this included in the initial cost?", "What happens if I am unhappy with the results? Who pays for the extra flights, hotel and remedial work?" and "Who can I contact for advice after the treatment?" Each of the three asks for a commitment that can be written down before travelling rather than an assurance offered afterwards.

Aftercare and guarantees appear as two separate items on the General Dental Council list, which is itself informative: "Is the work guaranteed for a certain period of time?" and "What aftercare do you provide?" A graft that has to integrate over months is exactly the case where those two come apart, because the period during which something can go wrong outlasts the visit. The regulator also advises a conversation at home first: "It’s always a good idea to speak to your own dentist before considering travelling abroad for your treatment, as they may be able to offer advice based on your dental history."

One section of the General Dental Council patient information is about promotion inside the United Kingdom rather than about treatment abroad. It states: "There are a number of providers coming to the UK to promote their services and encourage patients to travel overseas to have their dental treatment." The regulator then draws the legal line: "To work legally and safely all dental professionals must be registered with the GDC, and only people who are registered with us can legally practise dentistry in the UK." It names the activities that may fall inside that line: "It is possible that what takes place at these events may constitute the practice of dentistry – for example, assessments and advice." And it states the consequence: "Any patient who receives illegal dental treatment is placing themselves at risk as they will not be protected by the rigorous regulatory system that we have in place in the UK."

One thing the General Dental Council list does not contain was checked rather than assumed: no item on it names bone grafting, augmentation, or any other specific dental procedure. The list asks who, whether, what if, and who pays, and the regulator's framing in the same patient information is about regulation rather than clinical technique: "Dental regulation is likely to vary according to country, so it’s a good idea to do some initial research." Under the rules our methodology page sets out, an absence found by reading a document is reported as a measurement of that document rather than as a criticism of it.

## How is this searched in the UK, and how difficult is the term?

Search demand for the phrase bone grafting for dental implants in the United Kingdom was read by Semrush at three points and moved in two directions: 70, then 590, then 480 monthly searches. Under the measurement rules our methodology page sets out, a reading of that kind is a tool's estimate of query counts and nothing more; it counts neither patients, nor grafts placed, nor operations booked. The figures come from our own United Kingdom keyword dataset, held as en-olcum.json, and the same file records a keyword difficulty score of 28 for the phrase, which is the highest score attached to any of the twenty English terms on our target list.

Three sibling phrases ask the same question in different words, and our own keyword dataset records each of them separately: bone graft for dental implant at 390 searches a month, dental implants and bone grafts at 480, and cost of 2 dental implants with bone grafting at 260. Two of those strings, and the headline phrase itself, carry a difficulty score of 28, and the cost variant is scored at 15. Quoting the single headline phrase on its own would understate the demand behind the question, which is why our search map, kept under the reading rules our methodology page sets out, records the whole bone graft family at roughly 3,210 searches a month.

Three of the other keyword corpora held here do not contain this phrase at all, and each absence was checked rather than assumed. The question-mining file sorular-madencilik.json, which holds harvested question queries for our English targets, contains no row with the word graft in it. Neither does the English keyword universe file en-kelime-evreni-2026-08-03.json, nor the Moz Keyword Explorer harvest held as moz-keyword-explorer-hasadi.json. One tool measured this question and three of our other datasets do not contain it, and our methodology page requires that split to be printed rather than smoothed into a single confident number.

What a search volume can and cannot support is worth stating beside it. Our own keyword dataset labels the intent of this query as informational, which classifies the query rather than the person typing it. A rising count means the question is being asked more often; it does not mean more grafts are being placed, more are failing, or more people are travelling for surgery. A keyword tool cannot separate a person reading before treatment from a person worrying after it, and no dataset held here records which of the two typed the query. No clinical claim on this page is derived from a search number, and under our editorial standards page none may be.

One measurement attempted for this phrase came back empty, and the empty result is recorded rather than dropped. Our own keyword record for bone grafting for dental implants marks its AI-answer measurement as not carried out. This page therefore makes no claim about whether an AI answer is shown for the query, or which sites it cites. The same record carries the commercial signal the tool reports beside the volume, a cost-per-click of 1.61. What that figure prices is an advertising auction, and our editorial standards page rules out price promises, so no cost of treatment is stated or implied by it.

How the number was arrived at is recorded beside the reading rather than left implicit. The three readings held for this phrase come from one tool, taken at three points in time, and our methodology page requires the tool to be named and the reading dated whenever a volume is published. No second commercial tool returned a volume for this exact phrase anywhere in our corpus, so no cross-check is offered here and none is implied. A single-tool reading is published as a single-tool reading, and where a figure turns out to be wrong the change is logged on our corrections page.

## Why this page exists as a reference page rather than a traffic page

Our own search map opened this subject as a link target rather than a traffic target, and records the reason in those words. The entry notes that the most linked page on a competing dental travel site sat on the same condition-specific clinical axis this page belongs to, with 142 referring domains, while the terms that page was built on sit in the implants-and-diabetes family, which our own keyword dataset puts at roughly 440 searches a month in the United Kingdom with no single string in it above 40. A link target and a traffic target are two different things needing two different justifications, and under the rules our methodology page sets out that reasoning is published with the page it produced rather than left in a planning file.

The bone graft family is the largest English sub-theme on that axis in our own measurement, at roughly 3,210 searches a month across its strings, and simultaneously the hardest: the difficulty score attached to the main phrase is the highest in our English target list. A subject with real demand and a top difficulty score is not a quick ranking opportunity, and treating it as one would be a decision taken against our own measurement rather than with it. Under the reading rules our methodology page sets out, a difficulty score is a tool's estimate of competition and not a statement about the subject.

What once held this page in draft was a condition we could point at, and it was neither a shortage of sources nor a missing approval. The approval exists, is written and dated, and covers this page along with the rest of the site; a named medical editor has been appointed, and this page names its writer and its checker at the foot. What was missing sat in our own record-keeping: this page's blocks are classified in our passage table — the table that carries the evidence class of each passage, and from which a page's own class is derived — and twenty-three of them are readings of ours rather than quotations, which our build will not publish without a page-by-page clinician review line recorded against them. That line is now recorded: the medical editor read this page and a dated signature record, bound by a hash to those twenty-three passages, was written against it on 3 September 2026. The date sits in that record rather than on the page, and that is printed here rather than worked around, because a page that hides its own conditions is harder to check than one that states them.

What this page does not do follows from the same standards. It does not rank clinics, recommend a dentist, quote a price for a graft, or offer any route to book treatment, in Turkey or anywhere else. We are not a clinic, an agency or a booking service, and no figure quoted here was measured in a Turkish clinic. Every clinical sentence on this page is either a quotation from a named published source, a statement about what a named source does not say, or a reading of ours, and our editorial standards page is where that division comes from.

How large the gap is between what this site can publish and what people are asking was measured. Our own search map once printed a ratio between the questions answerable with attribution alone and the clinical mass that needs a named clinician's signature, and our own refutation file then rejected it: the larger of the two figures adds three quantities that the same document says cannot be added to one another — an interface-level family total, an interface-level variation total and three head-term volumes. No ratio is printed here, and the gap is left as a tension still open rather than a number.

The order in which sources were tested on this page is fixed rather than chosen case by case: author line first, then institution, then whether one paper cites the other, then whether both rest on a common ancestor document. A source failing the first test is not rescued by the other three. Applying that order removed one candidate from this page, and the removal is named in the section it would have supported rather than quietly absorbed. A source that was considered and rejected is recorded on the page it would have supported rather than kept as an internal note.

Where the published record stops is part of what this page reports. There is no guideline from the National Institute for Health and Care Excellence on dental implant treatment, there is no dedicated dental bone graft page on the NHS website, and none of the systematic reviews quoted here reports its outcomes by the country in which the surgery was carried out. Each of those is an absence that was searched for and written down. Where a figure on this page later turns out to be wrong, the change is logged on our corrections page instead of being edited away.

## Sources used on this page

- Cambridge University Hospitals NHS Foundation Trust — Bone grafting for dental implants, 2024-07-15
- Gurbanov S, Plugmann P, Oral Health & Preventive Dentistry 2024, PMID 39555856
- Silva LD et al., International Journal of Oral and Maxillofacial Surgery 2016, PMID 27765427
- Aloy-Prosper A et al., Medicina Oral Patologia Oral y Cirugia Bucal 2015, PMID 25662543
- Nkenke E, Stelzle F, Clinical Oral Implants Research 2009, PMID 19663959
- Slagter KW et al., Journal of Periodontology 2021, PMID 33724473
- Danesh-Sani SA et al., Journal of Periodontal Research 2017, PMID 27534916
- Moghaddas O et al., Journal of Advanced Periodontology and Implant Dentistry 2022, PMID 36714084
- McKenna GJ et al., Journal of Evidence-Based Dental Practice 2022, PMID 36162883
- NHS England — Avoidance of doubt: Clinical policy for self-funded dental treatment requiring NHS intervention, 2024-11-04
- General Dental Council — Going abroad for dental treatment
- _calisma/plan-olcum/en-olcum.json